Phase 2 × Completed × Immunoglobulin Light-chain Amyloidosis × Clear all S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Phase 2 Completed
43 enrolled 23 charts
EMN27
Phase 2 Completed
35 enrolled
A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis
Phase 2 Completed
25 enrolled 14 charts
Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load
Phase 2 Completed
19 enrolled
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Phase 2 Completed
35 enrolled 7 charts
COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
Phase 2 Completed
119 enrolled 11 charts
High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
Phase 2 Completed
60 enrolled
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
Phase 2 Completed
41 enrolled 12 charts
DUAL
Phase 2 Completed
32 enrolled 15 charts
Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Phase 2 Completed
35 enrolled 9 charts
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
Phase 2 Completed
80 enrolled 7 charts
PRONTO
Phase 2 Completed
129 enrolled 18 charts
S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
Phase 2 Completed
104 enrolled 6 charts
Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis
Phase 2 Completed
28 enrolled
Safety and Effect of Doxycycline in Patients With Amyloidosis
Phase 2 Completed
25 enrolled 13 charts
LENDEXAL
Phase 2 Completed
30 enrolled
CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
82 enrolled 9 charts
MRD
Phase 2 Completed
16 enrolled 9 charts
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
Phase 2 Completed
239 enrolled 23 charts
Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
10 enrolled 9 charts
Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis
Phase 2 Completed
40 enrolled 5 charts
S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
93 enrolled
Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis
Phase 2 Completed
2 enrolled 9 charts
LEOMEX
Phase 2 Completed
50 enrolled
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
35 enrolled 11 charts
High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
Phase 2 Completed
451 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
Phase 2 Completed
75 enrolled
Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis
Phase 2 Completed
4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
45 enrolled
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Phase 2 Completed
171 enrolled
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA
Phase 2 Completed
58 enrolled
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
Phase 2 Completed
High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis
Phase 2 Completed
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Phase 2 Completed
Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis
Phase 2 Completed
25 enrolled